PMC:7172841 / 10106-10422 JSONTXT

{"project":"LitCovid-PD-MONDO","denotations":[{"id":"T100","span":{"begin":4,"end":12},"obj":"Disease"},{"id":"T101","span":{"begin":143,"end":151},"obj":"Disease"},{"id":"T102","span":{"begin":156,"end":159},"obj":"Disease"}],"attributes":[{"id":"A100","pred":"mondo_id","subj":"T100","obj":"http://purl.obolibrary.org/obo/MONDO_0100096"},{"id":"A101","pred":"mondo_id","subj":"T101","obj":"http://purl.obolibrary.org/obo/MONDO_0100096"},{"id":"A102","pred":"mondo_id","subj":"T102","obj":"http://purl.obolibrary.org/obo/MONDO_0015545"}],"text":"CAP COVID-19\nIntermediate 21/40 [52.5 (27.5-67.1)] 0/26 [0 (0-12.9)] \u003c0.0001\nImmunoparalysis (for bacterial CAP) and immune dysregulation (for COVID-19) or MAS 35/64 [54.7 (42.6-66.3)] 28/28 [100 (87.9-100)] \u003c0.0001\n∗comparisons by the Fisher exact test. Abbreviation is as follows: CI, confidence interval.\n\nMajor D"}

{"project":"LitCovid-PD-CLO","denotations":[{"id":"T60","span":{"begin":160,"end":162},"obj":"http://purl.obolibrary.org/obo/CLO_0001000"},{"id":"T61","span":{"begin":249,"end":253},"obj":"http://purl.obolibrary.org/obo/UBERON_0000473"}],"text":"CAP COVID-19\nIntermediate 21/40 [52.5 (27.5-67.1)] 0/26 [0 (0-12.9)] \u003c0.0001\nImmunoparalysis (for bacterial CAP) and immune dysregulation (for COVID-19) or MAS 35/64 [54.7 (42.6-66.3)] 28/28 [100 (87.9-100)] \u003c0.0001\n∗comparisons by the Fisher exact test. Abbreviation is as follows: CI, confidence interval.\n\nMajor D"}

{"project":"LitCovid-sentences","denotations":[{"id":"T81","span":{"begin":13,"end":76},"obj":"Sentence"},{"id":"T82","span":{"begin":77,"end":215},"obj":"Sentence"},{"id":"T83","span":{"begin":216,"end":254},"obj":"Sentence"},{"id":"T84","span":{"begin":255,"end":307},"obj":"Sentence"}],"namespaces":[{"prefix":"_base","uri":"http://pubannotation.org/ontology/tao.owl#"}],"text":"CAP COVID-19\nIntermediate 21/40 [52.5 (27.5-67.1)] 0/26 [0 (0-12.9)] \u003c0.0001\nImmunoparalysis (for bacterial CAP) and immune dysregulation (for COVID-19) or MAS 35/64 [54.7 (42.6-66.3)] 28/28 [100 (87.9-100)] \u003c0.0001\n∗comparisons by the Fisher exact test. Abbreviation is as follows: CI, confidence interval.\n\nMajor D"}

{"project":"LitCovid-PD-HP","denotations":[{"id":"T47","span":{"begin":117,"end":137},"obj":"Phenotype"}],"attributes":[{"id":"A47","pred":"hp_id","subj":"T47","obj":"http://purl.obolibrary.org/obo/HP_0002958"}],"text":"CAP COVID-19\nIntermediate 21/40 [52.5 (27.5-67.1)] 0/26 [0 (0-12.9)] \u003c0.0001\nImmunoparalysis (for bacterial CAP) and immune dysregulation (for COVID-19) or MAS 35/64 [54.7 (42.6-66.3)] 28/28 [100 (87.9-100)] \u003c0.0001\n∗comparisons by the Fisher exact test. Abbreviation is as follows: CI, confidence interval.\n\nMajor D"}

{"project":"LitCovid-PMC-OGER-BB","denotations":[{"id":"T387","span":{"begin":211,"end":221},"obj":"SP_7"},{"id":"T388","span":{"begin":251,"end":254},"obj":"PR:000001004"},{"id":"T389","span":{"begin":255,"end":259},"obj":"PR:000001006"},{"id":"T390","span":{"begin":261,"end":272},"obj":"CL:0000542"},{"id":"T391","span":{"begin":286,"end":290},"obj":"PR:000001006"},{"id":"T392","span":{"begin":292,"end":303},"obj":"CL:0000542"}],"text":"CAP COVID-19\nIntermediate 21/40 [52.5 (27.5-67.1)] 0/26 [0 (0-12.9)] \u003c0.0001\nImmunoparalysis (for bacterial CAP) and immune dysregulation (for COVID-19) or MAS 35/64 [54.7 (42.6-66.3)] 28/28 [100 (87.9-100)] \u003c0.0001\n∗comparisons by the Fisher exact test. Abbreviation is as follows: CI, confidence interval.\n\nMajor D"}

{"project":"LitCovid-PubTator","denotations":[{"id":"333","span":{"begin":4,"end":12},"obj":"Disease"},{"id":"334","span":{"begin":72,"end":92},"obj":"Disease"},{"id":"335","span":{"begin":143,"end":151},"obj":"Disease"}],"attributes":[{"id":"A333","pred":"tao:has_database_id","subj":"333","obj":"MESH:C000657245"},{"id":"A335","pred":"tao:has_database_id","subj":"335","obj":"MESH:C000657245"}],"namespaces":[{"prefix":"Tax","uri":"https://www.ncbi.nlm.nih.gov/taxonomy/"},{"prefix":"MESH","uri":"https://id.nlm.nih.gov/mesh/"},{"prefix":"Gene","uri":"https://www.ncbi.nlm.nih.gov/gene/"},{"prefix":"CVCL","uri":"https://web.expasy.org/cellosaurus/CVCL_"}],"text":"CAP COVID-19\nIntermediate 21/40 [52.5 (27.5-67.1)] 0/26 [0 (0-12.9)] \u003c0.0001\nImmunoparalysis (for bacterial CAP) and immune dysregulation (for COVID-19) or MAS 35/64 [54.7 (42.6-66.3)] 28/28 [100 (87.9-100)] \u003c0.0001\n∗comparisons by the Fisher exact test. Abbreviation is as follows: CI, confidence interval.\n\nMajor D"}